RO4929097

RO4929097 has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Sep 1, 2022: “RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model”.

Intervention

1 paper studies it6 findingsUpdated

PubChemChEBI

See all 1 papers on RO4929097

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country; 1 trial, none about aging, 1 with no results posted.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • 1 trial, none about aging, 1 with no results posted
  • Animals1

What did studies of RO4929097 find?

5

Studies of RO4929097 measured 5 outcomes, among them epithelial-mesenchymal transition, MAPK/ERK signaling and notch signaling.

epithelial-mesenchymal transition

downin human cells1downin mice1

1 study
  1. RO4929097 inhibits epithelial-mesenchymal transition in human cells (TGFβ1-treated cells).

    “The inhibition of RO on EMT was further confirmed in TGFβ1-treated phRPE cells.”

    CellsTGFβ1-treated cellsprimary human retinal pigment epithelial cell

    RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model

    Investigative ophthalmology & visual science

  2. RO4929097 inhibits epithelial-mesenchymal transition in mice (laser-induced mouse model).

    “EMT and Notch activation in RPE-choroid complexes from laser-induced mice were significantly attenuated by RO.”

    Animalslaser-induced mouse modelRPE-choroid complexmales

    RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model

    Investigative ophthalmology & visual science

MAPK/ERK signaling

downin human cells1

1 study
  1. RO4929097 inhibits MAPK/ERK signaling in human cells (Notch signaling blockade).

    “Blockage of Notch signaling by RO could inhibit ERK1/2 signaling”

    CellsNotch signaling blockaderetinal pigment epithelial cell

    RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model

    Investigative ophthalmology & visual science

More on MAPK/ERK signaling

Notch signaling

downin mice1

1 study
  1. RO4929097 inhibits notch signaling in mice (laser-induced mouse model).

    “EMT and Notch activation in RPE-choroid complexes from laser-induced mice were significantly attenuated by RO.”

    Animalslaser-induced mouse modelRPE-choroid complexmales

    RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model

    Investigative ophthalmology & visual science

More on Notch signaling

Choroidal neovascularization

downin mice1

1 study
  1. RO4929097 decreases choroidal neovascularization in mice (laser-induced mouse model).

    “Intravitreal injection of RO reduced the sizes of both CNV and subretinal fibrosis in laser-induced young and old mice”

    Animalslaser-induced mouse modelchoroidday 7 and day 14 after laser inductionmales

    RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model

    Investigative ophthalmology & visual science

More on Choroidal neovascularization

Subretinal fibrosis

downin mice1

1 study
  1. RO4929097 decreases subretinal fibrosis in mice (laser-induced mouse model).

    “Intravitreal injection of RO reduced the sizes of both CNV and subretinal fibrosis in laser-induced young and old mice”

    Animalslaser-induced mouse modelsubretinal tissueday 7 and day 14 after laser inductionmales

    RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model

    Investigative ophthalmology & visual science

More on Subretinal fibrosis

Trial sponsors

Latest